Key points are not available for this paper at this time.
Introduction: Thyroid cancer 5th most common cause of cancer. Predominant in females with incidence of 3:1. median age 50 yrs. 5 years survival rate of 95%. PTC infrequently cause distant metastasis with bone metastasis in 4% of patients.1 Case Details: First case: 31/M Presented with U/L limb weakness gradually progressing to quadriparesis. Evaluation reveals spinal lesions at C5. Underwent C5 corpectomy with C4-C6 Cervical laminectomy. The HPE of C5-C6 lesions reveals metastatic follicular variant of PTC. Retrospective evaluation reveals thyrotoxic profile (TSH484 ng/ml) and was planned for another dose of RAI. Discussion: Toraiah EA et al., suggested the most common site of metastasis for PTC is Lungs (53.4%) followed by bone (28.1%).2 There is one Indian study by Karkuzhali P et al., from Madras who described 377 papillary thyroid carcinoma patients for various factors. They found that lymph node and metastasis elsewhere in 19.1 % of patients. They suggested that PTC in males is more multicentric than unicentric and the frequency of PTC is very less in males compared to females.3 Conclusion: Thyroid malignancies with distant metastases may present with thyrotoxicosis. Functional metastases should also be suspected in cases of minimal TSH elevation post thyroidectomy. All the cold nodules in the background of hyperthyroidism should be evaluated for malignancy. Timely follow up is mandatory for Ca THYROID patients for early detection of distant metastases.
Sonwane et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: